Quantity (per box / 10 vials)
A triple-receptor research compound targeting GLP-1, GIP, and glucagon pathways involved in metabolism and energy balance.
Retatrutide | 40 mg | 10 vials
A triple-receptor research compound targeting GLP-1, GIP, and glucagon pathways involved in metabolism and energy balance.
Retatrutide is a triple-receptor agonist that targets GLP-1, GIP, and glucagon receptors. That combination makes it especially interesting for research into appetite, energy use, glucose regulation, and body-composition pathways. This product is intended for research use only.
Important Notice: Purchase and use of this product are restricted to laboratories and research organizations for laboratory research and scientific analysis only. It is not intended for human or animal use, consumption, or administration.
Retatrutide is a triple-receptor agonist that targets GLP-1, GIP, and glucagon receptors. That combination makes it especially interesting for research into appetite, energy use, glucose regulation, and body-composition pathways. This product is intended for research use only.
Important Notice: Purchase and use of this product are restricted to laboratories and research organizations for laboratory research and scientific analysis only. It is not intended for human or animal use, consumption, or administration.